Literature DB >> 469373

Phenolsulphotransferase: enzyme activity and endogenous inhibitors in the human erythrocyte.

R J Anderson, R M Weinshilboum.   

Abstract

PST (E.C. 2.8.2.1) plays an important role in the metabolism of many drugs, catecholamine metabolites, and catecholamines. PST activity was detected in each of 178 human RBC lysates. When MHPG was used as a substrate, the activity ranged from 28 to 1385 U/ml of RBC, with an average value of 217.7 +/- 13.1 (mean +/- S.E.M.). However, there was not a direct relationship between quantity of RBC lysate and enzyme activity, an observation that raised the possibility of endogenous enzyme inhibitors. Therefore human RBC PST was partially purified (415-fold) to use in the study of tissue enzyme inhibitors. The pH optimum of the partially purified enzyme was 7.5, with an apparent Km value for [35S]PAPS of 0.46 microM and an apparent Km value for MHPG of 260 microM. When the partially purified enzyme was added to each of 20 human RBC lysates, its activity was inhibited an average of 91% +/- 0.6 (mean +/- S.E.M.). Endogenous inhibitors were also present in homogenates of human renal cortex and in homogenates of a variety of rat tissues. RBC lysates contained at least two PST inhibitors: a low-molecular-weight inhibitor (less than 2000) that was heat-, acid-, and base-stable, dialyzable, and resistant to digestion by chymotrypsin; and a high-molecular-weight inhibitor (greater than 65,000) that was heat-labile and nondialyzable. Whether the RBC enzyme activity may serve as an indicator of PST activity in less accessible tissues remains to be determined. However, the first step toward testing this hypothesis will require the accurate measurement of PST activity in tissue preparations by a procedure that removes or inactivates enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 469373

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Influence of phosphate, sulfonic, and sulfamic acids on sulfoconjugate release in the vascularly perfused mouse small intestine.

Authors:  P Wollenberg; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

2.  Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.

Authors:  U K Walle; G R Pesola; T Walle
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

3.  Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide.

Authors:  S M Bonham Carter; G Rein; V Glover; M Sandler; J Caldwell
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

4.  The effect of ascorbic acid on the sulphate conjugation of ingested noradrenaline and dopamine.

Authors:  J W Dunne; L Davidson; R Vandongen; L J Beilin; A M Tunney; P B Rogers
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

5.  Sulphation by cultured cells. Cysteine, cysteinesulphinic acid and sulphite as sources for proteoglycan sulphate.

Authors:  D E Humphries; C K Silbert; J E Silbert
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

6.  Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation.

Authors:  C Reiter; G Mwaluko; J Dunnette; J Van Loon; R Weinshilboum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

7.  Steroid hormone sulphation in lead workers.

Authors:  P Apostoli; L Romeo; E Peroni; A Ferioli; S Ferrari; F Pasini; F Aprili
Journal:  Br J Ind Med       Date:  1989-03

8.  Studies on the meta and para O-sulphation of the catechol compound 3,4-dihydroxybenzoic acid by rat liver sulphotransferase in vitro.

Authors:  E J Pennings; G M Van Kempen
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.